Latigo Biotherapeutics, Inc.

Latigo Biotherapeutics, Inc. financial statements

Latigo Biotherapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 109.17MEODHD
Cash and equivalentsUSD 69.44MEODHD

Latigo Biotherapeutics, Inc. financials on 6ix · Latigo Biotherapeutics, Inc. on 6ix